Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion 

Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85. https://doi.org/10.1182/blood-2004-09-3502.

Article  CAS  PubMed  Google Scholar 

Dobos G, Pohrt A, Ram-Wolff C, Lebbé C, Bouaziz JD, Battistella M, et al. Epidemiology of cutaneous T-cell lymphomas: a systematic review and meta-analysis of 16,953 patients. Cancers (Basel). 2020;12(10):2921. https://doi.org/10.3390/cancers12102921.

Article  CAS  PubMed Central  Google Scholar 

Kaufman AE, Patel K, Goyal K, O’Leary D, Rubin N, Pearson D, et al. Mycosis fungoides: developments in incidence, treatment and survival. J Eur Acad Dermatol Venereol. 2020;34(10):2288–94. https://doi.org/10.1111/jdv.16325.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maguire A, Puelles J, Raboisson P, Chavda R, Gabriel S, Thornton S. Early-stage mycosis fungoides: epidemiology and prognosis. Acta Derm Venereol. 2020;100(1):adv00013. https://doi.org/10.2340/00015555-3367.

Article  PubMed  Google Scholar 

Ottevanger R, de Bruin DT, Willemze R, Jansen PM, Bekkenk MW, de Haas ERM, et al. Incidence of mycosis fungoides and Sezary syndrome in the Netherlands between 2000 and 2020. Br J Dermatol. 2021;185(2):434–5. https://doi.org/10.1111/bjd.20048.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Larocca C, Kupper T. Mycosis fungoides and Sezary syndrome: an update. Hematol Oncol Clin N Am. 2019;33(1):103–20. https://doi.org/10.1016/j.hoc.2018.09.001.

Article  Google Scholar 

Scarisbrick J. Staging of mycosis fungoides and Sézary syndrome: time for an update? EMJ Allergy Immunol. 2018;6(1):92–100.

Google Scholar 

Olsen E, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from ISCL, USCLC, and EORTC. Blood. 2022;140(5):419–37. https://doi.org/10.1182/blood-2007-03-055749.

Article  CAS  PubMed  Google Scholar 

Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28(31):4730–9. https://doi.org/10.1200/JCO.2009.27.7665.

Article  PubMed  Google Scholar 

Demierre MF, Gan S, Jones J, Miller DR. Significant impact of cutaneous T-cell lymphoma on patients’ quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer. 2006;107(10):2504–11. https://doi.org/10.1002/cncr.22252.

Article  PubMed  Google Scholar 

Molloy K, Jonak C, Woei AJF, Guenova E, Busschots AM, Bervoets A, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2020;182(3):770–9. https://doi.org/10.1111/bjd.18089.

Article  CAS  PubMed  Google Scholar 

Russomanno K, Carver DeKlotz CM. Acceleration of cutaneous T-cell lymphoma following dupilumab administration. JAAD Case Rep. 2021;8:83–5. https://doi.org/10.1016/j.jdcr.2020.12.010.

Article  PubMed  Google Scholar 

Hollins LC, Wirth P, Fulchiero GJ Jr, Foulke GT. Long-standing dermatitis treated with dupilumab with subsequent progression to cutaneous T-cell lymphoma. Cutis. 2020;106(2):E8–11. https://doi.org/10.12788/cutis.0074.

Article  PubMed  Google Scholar 

Martinez-Escala ME, Posligua AL, Wickless H, Rutherford A, Sable KA, Rubio-Gonzalez B, et al. Progression of undiagnosed cutaneous lymphoma after anti-tumor necrosis factor-alpha therapy. J Am Acad Dermatol. 2018;78(6):1068–76. https://doi.org/10.1016/j.jaad.2017.12.068.

Article  PubMed  PubMed Central  Google Scholar 

Amitay-Laish I, Guenova E, Ortiz-Romero PL, Vico-Alonso C, Rozati S, Geskin LJ, et al. The course of mycosis fungoides under cytokine pathway blockers: a multicentre analysis of real-life clinical data. Acta Derm Venereol. 2020;100(16):adv00277. https://doi.org/10.2340/00015555-3642.

Article  PubMed  Google Scholar 

Hoot JW, Wang L, Kho T, Akilov OE. The effect of phototherapy on progression to tumors in patients with patch and plaque stage of mycosis fungoides. J Dermatol Treat. 2018;29(3):272–6. https://doi.org/10.1080/09546634.2017.1365113.

Article  Google Scholar 

van Doorn R, Van Haselen CW, van Voorst Vader PC, Geerts ML, Heule F, de Rie M, et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol. 2000;136(4):504–10. https://doi.org/10.1001/archderm.136.4.504.

Article  PubMed  Google Scholar 

Pavlotsky F, Hodak E, Dawood M, Barzilai A. Stage IA mycosis fungoides should be treated until proven otherwise. J Am Acad Dermatol. 2020;82(1):e19–20. https://doi.org/10.1016/j.jaad.2019.09.001.

Article  PubMed  Google Scholar 

Trautinger F, Eder J, Assaf C, Bagot M, Cozzio A, Dummer R, et al. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome—update 2017. Eur J Cancer. 2017;77:57–74. https://doi.org/10.1016/j.ejca.2017.02.027.

Article  PubMed  Google Scholar 

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M, Committee EG. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv30–40. https://doi.org/10.1093/annonc/mdy133.

Article  CAS  PubMed  Google Scholar 

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Primary Cutaneous Lymphomas. Version 2.2021. 2020. https://www.nccn.org/professionals/physician_gls/pdf/primary_cutaneous.pdf. Accessed 28 July, 2021.

Quaglino P, Prince HM, Cowan R, Vermeer M, Papadavid E, Bagot M, et al. Treatment of early-stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol. 2021;184(4):722–30. https://doi.org/10.1111/bjd.19252.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hodak E, Amitay-Laish I. Mycosis fungoides: a great imitator. Clin Dermatol. 2019;37(3):255–67. https://doi.org/10.1016/j.clindermatol.2019.01.004.

Article  PubMed  Google Scholar 

Pimpinelli N, Olsen EA, Santucci M, Vonderheid E, Haeffner AC, Stevens S, et al. Defining early mycosis fungoides. J Am Acad Dermatol. 2005;53(6):1053–63. https://doi.org/10.1016/j.jaad.2005.08.057.

Article  PubMed  Google Scholar 

Scarisbrick JJ, Quaglino P, Prince HM, Papadavid E, Hodak E, Bagot M, et al. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients. Br J Dermatol. 2019;181(2):350–7. https://doi.org/10.1111/bjd.17258.

Article  CAS  PubMed  Google Scholar 

Santucci M, Biggeri A, Feller AC, Burg G, For the European Organization for Research, Treatment of Cancer Cutaneous Lymphoma Project Group. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous t-cell lymphoma: An EORTC Cutaneous Lymphoma Project Group study. Arch Dermatol. 2000;136(4):497–502. https://doi.org/10.1001/archderm.136.4.497.

Article  CAS  PubMed  Google Scholar 

Furlan FC, Sanches JA. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology. Bras Dermatol. 2013;88(6):954–60. https://doi.org/10.1590/abd1806-4841.20132336.

Article  Google Scholar 

Keehn CA, Belongie IP, Shistik G, Fenske NA, Glass LF. The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control. 2007;14(2):102–11. https://doi.org/10.1177/107327480701400203.

Article  PubMed  Google Scholar 

Chairatchaneeboon M, Thanomkitti K, Kim EJ. Parapsoriasis—a diagnosis with an identity crisis: a narrative review. Dermatol Ther. 2022. https://doi.org/10.1007/s13555-022-00716-y.

Article  Google Scholar 

Vakeva L, Sarna S, Vaalasti A, Pukkala E, Kariniemi AL, Ranki A. A retrospective study of the probability of the evolution of parapsoriasis en plaques into mycosis fungoides. Acta Dermatovenereol. 2005;85(4):318–23. https://doi.org/10.1080/00015550510030087.

Article  Google Scholar 

Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol. 1996;132(5):567–72.

Article  CAS  PubMed  Google Scholar 

Belousova IE, Vanecek T, Samtsov AV, Michal M, Kazakov DV. A patient with clinicopathologic features of small plaque parapsoriasis presenting later with plaque-stage mycosis fungoides: report of a case and comparative retrospective study of 27 cases of “nonprogressive” small plaque parapsoriasis. J Am Acad Dermatol. 2008;59(3):474–82. https://doi.org/10.1016/j.jaad.2008.05.028.

Article  PubMed  Google Scholar 

Guitart J, Kennedy J, Ronan S, Chmiel JS, Hsiegh YC, Variakojis D. Histologic criteria for the diagnosis of mycosis fungoides: proposal for a grading system to standardize pathology reporting. J Cutan Pathol. 2001;28(4):174–83. https://doi.org/10.1034/j.1600-0560.2001.028004174.x.

Article  CAS  PubMed  Google Scholar 

Zackheim HS, McCalmont TH. Mycosis fungoides: the great imitator. J Am Acad Dermatol. 2002;47(6):914–8. https://doi.org/10.1067/mjd.2002.124696.

Article  PubMed  Google Scholar 

Song SX, Willemze R, Swerdlow SH, Kinney MC, Said JW. Mycosis fungoides: report of the 2011 Society for Hematopathology/European Association for Haematopathology workshop. Am J Clin Pathol. 2013;139(4):466–90. https://doi.org/10.1309/AJCPOBDP2OQAJ5BR.

Article  CAS  PubMed  Google Scholar 

Alsayyah A. Is it mycosis fungoides? A comprehensive guide to reaching the diagnosis and avoiding common pitfalls. Ann Diagn Pathol. 2020;47: 151546. https://doi.org/10.1016/j.anndiagpath.2020.151546.

Article  PubMed  Google Scholar 

Virmani P, Myskowski PL, Pulitzer M. Unusual variants of mycosis fungoides. Diagn Histopathol (Oxf). 2016;22(4):142–51. https://doi.org/10.1016/j.mpdhp.2016.04.004.

Article  PubMed  PubMed Central  Google Scholar 

Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14. https://doi.org/10.1182/blood-2018-11-881268.

留言 (0)

沒有登入
gif